Status:
COMPLETED
Mentored Clinical Career Award in Adolescent Substance Abuse
Lead Sponsor:
Boston Children's Hospital
Conditions:
Substance-Related Disorders
Eligibility:
All Genders
12-21 years
Phase:
NA
Brief Summary
The goal of this project is to determine the barriers to, and risks and benefits of random laboratory drug testing for adolescents with identified drug or alcohol problems.
Detailed Description
Use of drugs and alcohol is associated with a variety of health care problems, making settings where adolescents receive routine medical care ideal for implementation of routine screening and early in...
Eligibility Criteria
Inclusion
- Adolescents ages 12-21
- Participants must have use of alcohol, cannabis, or another substance on at least 2 occasions in the 30 days preceding their initial assessment or 6 or more times in the past 90 days
- Participants must have health insurance or be willing to pay for the laboratory costs associated with drug testing.
- Participants must provide informed assent and, for those under 18, parental consent.
Exclusion
- Participants who require immediate hospitalization or immediate referral to residential substance abuse treatment
- Participants who cannot understand or read English at a 6th grade reading level
- Participants who are enrolled in the ASAP buprenorphine program
- Participants who report previous use of inhalants or any other substance that is not easily detected with urine drug testing
Key Trial Info
Start Date :
March 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 31 2013
Estimated Enrollment :
96 Patients enrolled
Trial Details
Trial ID
NCT00622219
Start Date
March 1 2008
End Date
August 31 2013
Last Update
June 21 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Hospital Boston
Boston, Massachusetts, United States, 02115